Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Brazil Pharmaceuticals and Healthcare Report Q3 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Brazil Pharmaceuticals and Healthcare Report Q3 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Brazil
- Number of Pages: 89
Executive Summary 5
Brazil Pharmaceuticals And Healthcare Industry SWOT ... 6
Brazil Political SWOT .... 6
Brazil Economic SWOT .. 7
Brazil Business Environment SWOT................ 7
Pharmaceutical Business Environment Ratings .8
Table: Americas Pharmaceutical Business Environment R 8
Limits Of Potential Returns........ 8
Risks To Realisation Of Returns 9
Brazil – Market Summary ............10
Regulatory Regime ...............12
Intellectual Property ..... 12
Regulator Interference .. 13
Data Protection ............ 14
Compulsory Licensing .. 14
Intellectual Property Environment 16
Other Regulatory Issues 20
Subsidies On Generics .. 22
Tax Burden On Pharmaceuticals .. 22
Industry Developments ..............24
Healthcare Sector ......... 24
Domestic Pharmaceutical Industry................ 27
State-Owned Manufacturing Sector ............... 27
PROFARMA Initiative .. 28
Generics Sector ............. 30
Multinational Research-Based Sector............ 32
Industry Forecast Scenario ............36
Overall Market Forecast.......... 36
Table: Brazilian Drug Market Trends............ 37
Key Growth Factors – Industry 38
Table: Brazilian Health Expenditure Trends . 39
Key Growth Factors – Macroeconomic ......... 40
Table: Brazil – Economic Activity 41
Prescription Market Forecast.. 42
Table: Brazil’s Prescription Drug Market Trends (US$mn unless otherwise stated) .............. 43
OTC Market Forecast ... 43
Regulatory Overview .... 44
Advertising ... 45
OTC Sector: Competitive Landscape............. 46
Key Growth Factors ...... 46
Table: Brazil’s OTC Market Trends (US$mn unless otherwise stated) .. 47
Generics Market Forecast ....... 48
Competitive Landscape . 49
Table: Brazil’s Generics And Patented Market Forecasts ... 50
Medical Device Market Forecast .. 51
Table: Brazil Medical Device Forecasts (US$mn unless otherwise stated) ...... 53
Table: Pharmaceutical Trade Data And Forecasts (US$mn) ................ 55
Other Healthcare Data Forecasts . 56
Table: Socio-Demographic Forecasts............ 56
Key Risks To BMI’s Forecast Scenario.......... 56
Competitive Landscape .............57
Leading Products .......... 57
Manufacturers .............. 57
Distribution .. 58
Retail Market ................ 59
Company Monitor 61
Leading Multinational Companies 61
Sanofi-Aventis ............... 61
Pfizer ...... 63
Merck & Co . 65
Novartis .. 67
GlaxoSmithKline (GSK) 69
Roche ...... 71
Nycomed (Altana Pharma)....... 72
Merck KGaA 73
Novo Nordisk ................ 74
Indigenous Manufacturing Sector. 76
Aché / Biosintética ........ 76
EMS Sigma .. 79
Eurofarma .... 81
Medley .... 83
BMI Forecast Modelling .............85
How We Generate Our Pharmaceutical Industry Forecasts ..... 85
Pharmaceutical Business Environment Ratings Methodology .. 86
Ratings Overview .......... 86
Table: Pharmaceutical Business Environment Indicators ... 87
Weighting 88
Table: Weighting Of Components . 88
Sources ........ 88
Brazil Pharmaceuticals And Healthcare Industry SWOT ... 6
Brazil Political SWOT .... 6
Brazil Economic SWOT .. 7
Brazil Business Environment SWOT................ 7
Pharmaceutical Business Environment Ratings .8
Table: Americas Pharmaceutical Business Environment R 8
Limits Of Potential Returns........ 8
Risks To Realisation Of Returns 9
Brazil – Market Summary ............10
Regulatory Regime ...............12
Intellectual Property ..... 12
Regulator Interference .. 13
Data Protection ............ 14
Compulsory Licensing .. 14
Intellectual Property Environment 16
Other Regulatory Issues 20
Subsidies On Generics .. 22
Tax Burden On Pharmaceuticals .. 22
Industry Developments ..............24
Healthcare Sector ......... 24
Domestic Pharmaceutical Industry................ 27
State-Owned Manufacturing Sector ............... 27
PROFARMA Initiative .. 28
Generics Sector ............. 30
Multinational Research-Based Sector............ 32
Industry Forecast Scenario ............36
Overall Market Forecast.......... 36
Table: Brazilian Drug Market Trends............ 37
Key Growth Factors – Industry 38
Table: Brazilian Health Expenditure Trends . 39
Key Growth Factors – Macroeconomic ......... 40
Table: Brazil – Economic Activity 41
Prescription Market Forecast.. 42
Table: Brazil’s Prescription Drug Market Trends (US$mn unless otherwise stated) .............. 43
OTC Market Forecast ... 43
Regulatory Overview .... 44
Advertising ... 45
OTC Sector: Competitive Landscape............. 46
Key Growth Factors ...... 46
Table: Brazil’s OTC Market Trends (US$mn unless otherwise stated) .. 47
Generics Market Forecast ....... 48
Competitive Landscape . 49
Table: Brazil’s Generics And Patented Market Forecasts ... 50
Medical Device Market Forecast .. 51
Table: Brazil Medical Device Forecasts (US$mn unless otherwise stated) ...... 53
Table: Pharmaceutical Trade Data And Forecasts (US$mn) ................ 55
Other Healthcare Data Forecasts . 56
Table: Socio-Demographic Forecasts............ 56
Key Risks To BMI’s Forecast Scenario.......... 56
Competitive Landscape .............57
Leading Products .......... 57
Manufacturers .............. 57
Distribution .. 58
Retail Market ................ 59
Company Monitor 61
Leading Multinational Companies 61
Sanofi-Aventis ............... 61
Pfizer ...... 63
Merck & Co . 65
Novartis .. 67
GlaxoSmithKline (GSK) 69
Roche ...... 71
Nycomed (Altana Pharma)....... 72
Merck KGaA 73
Novo Nordisk ................ 74
Indigenous Manufacturing Sector. 76
Aché / Biosintética ........ 76
EMS Sigma .. 79
Eurofarma .... 81
Medley .... 83
BMI Forecast Modelling .............85
How We Generate Our Pharmaceutical Industry Forecasts ..... 85
Pharmaceutical Business Environment Ratings Methodology .. 86
Ratings Overview .......... 86
Table: Pharmaceutical Business Environment Indicators ... 87
Weighting 88
Table: Weighting Of Components . 88
Sources ........ 88
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
